Chronic myeloid leukemia in children and adolescents: results of treatment with imatinib mesylate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronic myeloid leukemia in children and adolescents: results of treatment with imatinib mesylate

Published:2012-05-18 Issue:12 Volume:53 Page:2430-2433
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lakshmaiah K. C.,Bhise Rohan,Purohit Samit,Abraham Linu J.,Lokanatha D.,Suresh T. M.,Appaji L.,Arunakumari B. S.,Govindbabu K.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.694076

Reference18 articles.

1. Introduction

2. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

3. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

4. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (CML‐CP) in the tyrosine kinase inhibitor (TKI) era—Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort;British Journal of Haematology;2023-12-14

2. Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan;British Journal of Cancer;2023-01-30

3. Case Report of Renal Calculi in a Child Receiving Imatinib for Acute Lymphoblastic Leukemia;Canadian Journal of Kidney Health and Disease;2023-01

4. Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas;Cancers;2022-10-14

5. Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China;International Journal of Hematology;2021-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3